Integrated Advisors Network’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-29,726
Closed -$1.52M 720
2022
Q1
$1.52M Sell
29,726
-26,238
-47% -$1.26M 0.09% 236
2021
Q4
$3.13M Buy
55,964
+136
+0.2% +$6.89K 0.18% 140
2021
Q3
$2.65M Buy
55,828
+7,510
+16% +$383K 0.18% 149
2021
Q2
$2.25M Buy
48,318
+30,544
+172% +$1.34M 0.17% 152
2021
Q1
$709K Buy
+17,774
New +$702K 0.06% 260

Other funds holding RXL

Integrated Advisors Network's RXL Position: Q2 2022 in Review

Integrated Advisors Network sold out of ProShares Ultra Health Care (RXL) in Q2 2022, closing a stake of 29,726 shares — an estimated $1.52M sold.

Integrated Advisors Network first reported a position in RXL in Q1 2021 and held it in 5 quarters. The position peaked at $3.13M in Q4 2021. 24 funds tracked by Wall St. Rank hold RXL as of Q2 2022.

  • Integrated Advisors Network reported no remaining ProShares Ultra Health Care position as of Q2 2022 after selling out during the quarter.
  • Integrated Advisors Network sold 29,726 ProShares Ultra Health Care shares in Q2 2022, an estimated $1.52M.
  • Integrated Advisors Network first reported a position in ProShares Ultra Health Care in Q1 2021 and held it in 5 quarters.
  • Integrated Advisors Network's ProShares Ultra Health Care position peaked at $3.13M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2022.

Based on Integrated Advisors Network's 13F filing for Q2 2022, filed 12 Aug 2022.